ENDOMETRIAL

Clinical trials for ENDOMETRIAL explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL trials appear

Sign up with your email to follow new studies for ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

Experimental drug targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-stage study tests an experimental drug called SGN-MesoC2 in 19 adults with advanced solid tumors (like lung, ovarian, or pancreatic cancer) that have not responded to standard treatments. The drug is designed to stick to cancer cells and kill them. The main goals are t…

Matched conditions: ENDOMETRIAL

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated May 17, 2026 04:17 UTC

ENDOMETRIAL

Get alerted when new ENDOMETRIAL trials appear

Experimental drug targets Hard-to-Treat cancers in early trial